Table 2. Baseline data.
Variable | Complete Cohort n = 225 |
ASD +ve by DSM n = 128 |
ASD–ve by DSM n = 97 |
---|---|---|---|
Age (months) | |||
Mean ± SD | 54.59±29.14 | 58.58±31.15 | 49.33±5.47 |
Median | 47 | 49 | 44 |
IQR | 36–63.50 | 37–74 | 32.50–53.50 |
Range | 15–180 | 22–180 | 15–146 |
Gender, N(%) | |||
Males | 159 (70.7%) | 99 (77.3%) | 60 (61.9%) |
Development Quotient, N(%) | |||
≤50 | 115 (51.1%) | 77 (60.2%) | 38 (39.2%) |
51–60 | 64 (28.4%) | 43 (33.6%) | 21 (21.6%) |
61–70 | 33 (14.7%) | 5 (3.9%) | 28 (28.9%) |
71–80 | 8 (3.6%) | 2 (1.6%) | 6 (6.2%) |
81–90 | 2 (0.9%) | 0 | 2 (2.1%) |
>90 | 3 (1.3%) | 1 (0.8%) | 2 (2.1%) |
CARS Score, N(%) | |||
No autism (<30) | 106 (47.1%) | 11 (8.6%) | 95 (97.9%) |
Mild to Moderate (30–36.5) | 39 (17.3%) | 37 (28.9%) | 2 (2.1%) |
Severe (≥37) | 80 (35.6%) | 80 (62.5%) | 0 |